sk 1 blok moskulo a14

7/25/2019 Sk 1 Blok Moskulo a14

1/29

BLOKMUSKULOSKELETA

L

NYERI SENDI

A14


2/29

ANGGOTA KELOMPOKKETUA : ARLY FADHILLAH (1102014039)

SEKRETARIS : IBAL MUHAMMAD (1102014132)

ANGGOTA : AMINATU! !AHRAH (1102014019)

ANDHIKA SHAHNA! (1102014023)

ATIKA LAILANA (110201404")

D#I PERTI#I NINGSIH (11020140"9)

D#INTA ANGGRAINI (11020140$0)

EKA SYAFNITA (11020140$3)

FARI!AL ARIEF (110201409%)

HANI HANIFAH (1102014119)


3/29

Skenario 1

NYERI SENDI SIKU

S&'*+ ,-./,-. %0 * *+ -& R5 S-.&*+* -&,* 6&*. 6.- .6-* *7&. *

8&&*7 6& 5&*++*++ &**+ +&- ( range ofmovement / ROM) 6&- 2 8,* .*.

;SKENARIO BERTINGKAT&* 8&*+-- -&5&* >

5&6'>,*+&, I .,5. % 8,* 7*+ ,, *8&-*+ 6&&, 5.*5* '8 *. *7&. H6.,>&5&.-6* ,8''.5 .>. 7>&&?&5.D'-& 5&58&.-* *'*6&'. *. .*@56. +(NSAID) * .?'6.? > >6.&* &6&8


4/29

A. IDENTIFIKASI KATASULIT

H7>&&?&5. : K&,&8.* K.6, 65

R*+& ' 5'C&5&* : G&-* 7*+ > .,--*

6&*.. 6&? 5-6.5,

U.?'6.? : O8 7*+ 5&*.*+--* &-6-&6.

65 ,&= .*

M&6'>,*+&, I : I8 . --.

O,&?*'* : T'*',* > ,*+ ,*

NSAID : O8 7*+ 5&5.,.-. -6. *.>.&.-*,+&6.- *..*@56.


5/29

B. BRAIN STORMING

1 A> .+*'6.6 . 6?&*.' .6

2 A> >&*7&88 &. 7>&&?&5.

3 M&*+> 8&*+-- &. >5&6'>,*+&, I * ',&?*'*

4 A> >&*7&88 -&,* *7&. *

8&&*7

% A> ?' >&*?&6 . >&*7-. .*.

A> 6 >&5&.-6* 7*+ .,--**- 5&*&+--* .+*'6.6

" K&*> *7&. > 6.- >5&*++*++ ROM

$ A>- ROM 6&,, .6&88-* ',&7>&&?&5.

9 B+.5* 5&-*.65& -& '8NSAID * U.?'6.? ,55&*+'8. >&*7-. .*.

10 A>- &*.6 -&,5.* * 55&5>&*+. >&*7-. .*.

1 G' ..6

2 K&* +*++* 5&8',.65& >.*

3 B.6*7 &. > 6&*./6&*. .'6.6

4 K&* &&- . K.6, 65 7*+ 5 *

&,&>6*7 5&.'/5&.' .*@56.

% M-** 6&>&. -?*+/-?*+* 6. &*.6 -&,5.*

+*++* +.*, '8&6.6 * ,-'',

P&5&.-6* * .* 6&*.

" K&* 6-. 7*+ .6-* . K.6, 65 7*+

5&*5>-

$ T.- 6&,, -&* 8*7- -' ,.* 7*+ >5&*++*++ ROM

9 NSAID : M&*+58 6.*&6.6 >'6+,*.* 7*+

5&>-* 5&.' .*@56. 6&.*++ .*@56.8&-*+

U.?'6.?: M&*+58 &86'>6. 65 >+.*,

10 I7 ,-./,-. &=6 * =*. 5&*'>6& ,&8.

&** &-&* +' ..6> =*. 5&*'>6&

.-&*-* 8&-*+*7 '5'*& &6'+&*


6/29

C. HIPOTESIS

G' ..6 , >&*7-. 7*+ .6&88-* -&*>&*5>-* - 65 . ,5 P&*7-. .*.5&*7&88-* +&, .*@56. 8&> *7&. * 8&*+--

A>* -' 7*+ 5&*7&88-* * ,.* 5-**6&>&. -?*+/-?*+* 6. &*.6 -&,5.* +*++*+.*, '8&6.6 * ,-'', D.+*'6.6 . >&*7-. .*.> .&+--* ',& >&5&.-6* * ?.* 6&*.P&*+'8* 7*+ > .8&.-* , NSAID 8&*+6.5&*+58 6.*&6.6 >'6+,*.* 7*+ 5&>-*5&.' .*@56. 6&.*++ .*@56. 8&-*+ * 7*+,.**7 7. .?'6.? 7*+ 8&*+6. 5&*+58&86'>6. 65 > +.*,


7/29

D. SASARAN BELAJARLI 1 M&55. * 5&*&,6-* >&6&*.* **+6. , +&- 11 5-'6-'>.6

12 5.-'6-'>.6

LI 2 M&55. * 5&*&,6-* 5&8',.65&65

LI 3 M&55. * 5&*&,6-* G' A..6 31 &*.6.

32 &.','+.

33 >'6.','+. * >'+&*&6.6

34 5*.&66. -,.*.6

3% -'5>,.-6.

3 .+*'6.6 * .+*'6.6 8*.*+

3" >&5&.-6* ,8

3$ >&*,-6**


8/29

LI. 1 MEMAHAMI DAN MENJELASKAN

PERSENDIAN DAN FUNGSI ALAT GERAK

11 M-'6-'>.6

S.6&5 56-,'6-&,&, > 5*6. &.. .

,*+ '' * >&6&*.* (.8*',& &*'*,.+5&* * ,*+ =*) S.6&5 .*. 5&5*+-.*-*-. *- - 8&.. 8&,* 5&,--*-&+.* ,.**7 ,5 -&.>* 6&./. S&,.*6&8+. >&***+ * >&58&*- 8 ,*+

+ 8&*+6. 6&8+. >&,.**+ '+* ,5


9/29

Ekstremitas Superior

1 A.?,.' G,&*'5&,.6

2 A.?,.' 8.. (A.?,.' 5&',*.6 H5&'.,.6)

Otot- otot Shunt

Otot- otot Spurt

3 A.?,.' R.' ,*.6 P'.5,.6

4 A.?,.' R.' U,*.6 .6,.6

% A.?,.' R.'?>,.6

A.?,.' ?>'5&?>,&6A.?,.' ?>'5&?>,&6 I

A.?,.' ?>'5&?>,&6 II

" A.?,.' M&?>'>,*+&,.6A M&?>'>,*+&,.6 I

A M&?>'>,*+&,.6 II 65>. J

$ A.?,.'*&6 .*&>,*+&,.6


10/29

Ekstremitas Inferior

1 A.?,.' .*&.'.6 ,.8&.(.?,.' ?'&)

2 A.?,.' +&*6

3 A.?,.' .8.' 8,.6

4 A.?,.' ,'?,,.6% A.?,.' P&.6 A.?,.' ,'?,?*&'*C.?,.6

A.?,.' ?,?*&'?8'.&

A.?,.' 6'5&6,&6

A.?,.' M&6'>,*+&,&6

A.?,.'*&6 I*&>,*+&,&6 P&.6


11/29

K,6.-6. S&*.

1 B&6-* -&,6* +&-


12/29

1 A'.&(+,..*+)

2 G.*+,756 (.*+)

3 P.C' ('?'.&)

4 E,,.>6'.&(?'*7,'.&)

% S>&'.& ( 8,,* 6'?-&)

S&,,.6 (6,&)

2 B&6-* 8&*- >&5-* 6&*. * .>&>&+&-*


13/29

Bidang khayal tubuh

1 B.*+ ?''*,

2 B.*+ 6+.,

3 B.*+ *6C&6,

Gerak sendi tubuh

1 F,&-6.

2 E-6&*6.

3 A8-6.

4 A-6.

% E*''6.

E-6''6.

" L&'@&-6.

$ S.-5.-6.


14/29

12 M.-'6-'>.6

K&8*7-* 6&*. 8&6. >&5*&* * >.+','*+-* 8&6-* ?.. 66***7 5&*. 3+','*+* 5 :

1 F.8'6 (6&*. 8'6)2 K.,+.*'6 (6&*. ,*+ =*)

3 S7*'C., (6&*. 67*'C.,)


15/29

LI. 2 MEMAHAMI DAN MENJELASKAN

METABOLISME ASAM URAT


16/29

LI. 3 MEMAHAMI DAN

MENJELASKANARTHRITIS GOUT31 D&*.6.

A..6 G' , 6 >'6&6 .*@56.

(>&58&*+--*) 7*+ &. -&* &>'6.6. &>'6. .58** -.6, 65 > .*+* 6&-.6&*. ' M6, -* .58, 8., &8&*--.6,/-.6, . 5'*'6'.5 5'*'. >6&*./6&*. * .*+* 6&-.*7 K.6,/-.6, 8&

8&*- 5 .*., 7*+ 5&*+-.8-* &-6.>&*+*.*@56. 7*+ 8., 8&,* -*5&*+-.8-* *7&. &8


17/29

32 E.','+.

P&*7&88 &.*7 +' , *7 >&*.58**-.6, 65 . ,5 >&6&*.* 6&.*++ &.-&6-* ,'-,

P&*.*+-* - 65 ,5 .6&88-*',& 8&8&> -':

1 P&58&*-* >.*

2 G*++* -&,.** > +.*,


18/29

33 P'6.','+. * P'+&*&6.6


19/29

34 M*.&66. K,.*.6

G&, -6 . 6&*+* ..6 +' , +&, >&58&*+--*-&5&* *7&. &8 >*6 * +*++* +&- . 6&*. 7*+&6&*+ 7*+ &. 5&*- (-) 7*+ 5&*?>. >*?-*7-*+ . 24 5 L'-6. 7*+ >,.*+ 6&.*+ > 6&*+* >&5, 6&*. >*+-, .8 . --. G&, 55 7*+ 6&.*+ .6-*

> >&*&. +' * ,.*: >&+,/>&+, *7&. > 6&*. 6 ,.*> --. * *+* -..

B&8&> T> P&*7-. G' A65 U

T> 1: S&*+* +' -

T> 2: S.5 I*&-..-,

T> 3: G' .*+- ,*


20/29

DIAGNOSIS

T&> -.6, ,5 ?.* 6&*. '6 * 8., .&5-* .12 -.&. &6&8 . 8= .*.:

1 I*@56. 5-6.55 > .

>&5

2 S&*+* ..6 - ,&8. . 6-,.

3 A..6 *'*.-,&

4 S&*. 7*+ &-&* 8&=*-&5&*

% P&58&*+--* * 6-. > 6&*.5&6',*+&,

S&*+* > 6&*.5&6',*+&, *.,&,

" S&*+* > 6&*. 6, *.,&,

$ A*7 '-6

9 H.>&.6&5.

10 P '' 6.*/ 5>->&58&*+--* 6&*. 6.5&.6

11 P '' 6.*/ 5>- -.668-'.-, *> &'6.

12 K, 8-&. ?.* 6&*. *&+.

DIAGNOSIS BANDING

1 P6&'+'

2 O6&'..6

3 R&5'. ..6

3% D.+*'6.6 * D.+*'6.6 B*.*+


21/29

3 P&5&.-6* P&***+1 S&5 65

2 A*+- ,&-'6.

3 U.* 6>&6.5&* 24 5

4 A*,.6.6 ?.* 6>.6.

% P&5&.-6* .','+.


22/29

3" K'5>,.-6.

1 D&>'6.6. -.6, > ?.* 6.*'C.,5&*7&88-* >'6&6 .*@56. 7*+ 5&,.8-*5&.' -.5. 7*+ 5&*7&88-* C6'.,6.>&*.*+-* >&5&8.,.6 C6-, * -.C.6

-&5'-6.6 *- ,&-'6. >',.5''*-,&

2 N&',..6.6

3 G+, +.*, -


23/29

3$ P&*,-6**

1 NSAID (Non Steroidal Anti-inammatory !rugs)SALISILAT DAN SALISILAMID

2 KOLKISIN

3 ALOPURINOL

4 URIKOSURIK


24/29

F5-'.*5.-

1 E&- *,+&6.- :

S&*, : S,.6.,8&-& > .>',56

P&.& : M&*+58>&58&*-* >'6+,*.*. &5> &.*7 *+* 5&*?&+ 6&*6.6.&6&>' 6 6-. &>*+6*+ 5&-*.- -.5.

2 E&- *.>.&.- : S,.6., 8&-&5&*+&58,.-* *+6. &5'6 .H.>',56 -&58,. *'5,

F5-'-.*&.-

3 O, : 6&8+.* . 86'86. &*+*?&> ,5 8&*- . ,58*+

&>. 6&8+.* 8&6 . 66 ,68+.* 6

INDIKASI

1 A*.>.&6.6

2 D'6.6 &=6 : 32% 1000 5+>&', .> 3 4 5

3 D'6.6 *- *- : 20 5+-+BB.- 8',& ,&8. . 3 +.

4 A*,+&6.-

% D'6.6 &=6 : % $ + .

D'6.6 *- *- : 100 12%5+-+BB.

EFEK SAMPING

1 R&-6. ,&+.

2 S,* ?&* 8&> +6..6 *,-6 >&>.-5 -* &&- ..6.*7

3 S.*'5 &7&

"# SA$ISI$A% !AN SA$ISI$A&I!


25/29

F5-'.*5.-

O8 .*. 8&.-* &*+* >'&.*5.-'8, * 5&*7&88-*&>',.5&.66. * 5&*+.,*+*75.-'8, 8., +*,'6. * 6&,8&+&- ,.**7 H, .*. 5&*7&88-*

>&*+58* 5.+6. +*,'6. -& &5>*+ 6&.*++ 5&.' .*@56. 7*+ .58 * &6>'* .*@56. . &-*

F5-'-.*&.-

A86'86. 5&,,. 6,* ?&* 8.-D..6.86.-* 6&? ,6 ,5 8K .*++. . > . +.*, . ,.5>

* 6,* ?&* E-6-&6. 6&8+.* ,58&*- 5&,,. +.*, 10 /20 5&,,..*

I*.-6.

1 D'6.6 -',-.6.* 0% /0 5+ .> 512 5+6&8+. '6.6 =, ..-. 0% 0 5+ .> 25 .*++ +&, >&*7-. 5&*+.,*+ +&, 6,* ?&* .58, 5-6.5, " $ 5+U*- >',-6.6 .8&.-* 0% /1 5+ 6&.

2 P&58&.* IJ : 1 2 5+ . ,*-* &*+* 0%

5+ .> 12 /24 5 U*- 5&*?&+ ..6.-.8 &-6C66. 6&8.-*7 ,* 2 5,.&*?&-* .*++ 10 5, ,5 ,* +5,

E&- 65>.*+

1 M, 5* * .&

2 D&>&6. 6565 ,*+ >> *&..6

>&.& 5.'>. *. ,'>&6.

3 G*++* . : &-6. .*. 55*7 &.> >&58&.* IJ

'# (O$(ISIN


26/29

)# Alopurinol

B&*+6. *- 5&**-* - 6 A,'>.*', 8&-&&*+* 5&*+58 *.* '-6.6& #- > >&*&-?-> . 8&.-* 1 -,. 6&. E&- 65>.*+ 7*+ 6&.*+&. &-6. -,.

D'6.6 *- >.. .*+* : 200 400 5+ 6&.

D'6.6 *- >.. 8& : 400 00 5+ 6&.

U*- >6.&* &*+* +*++* +.*, : 100 200 5+ 6&.

U*- .>&6&5. 6&-*& 100 200 5+ 6&. *-*- *- 10 *: 300 5+ 6&. * *- . 8= *1%0 5+ 6&.


27/29

*# +rikosurik M&>-* '8 7*+ 5&*58 >&*+&,* 65 5&,,. . -&5. O8.-'6.- 8&-& 5&*+58 &86'86. 8,6 &> 65 7*+ &,. ,6. * 5&*+. >&*7.5>***7 M&*?&+ >&58&*-* '>. 7*+8

INDIKASI

P&*.*+-* &-&*6. 6&*+* * -&>**7 T.- &&-. *- >6.&*&*+* .*66.&*6. +.*,

PILIHAN OBATNYA :

1 P'8&*&. : '6.6 =, 0% +. . .*+--* 6&? 8&> 5&*. 1 /2+. M&*+58 &86'86. ',& +.*, E&- 65>.*+ 5, 5*.>&6&*6..6

2 S,*>.6'* : '6.6 =, 100 5+. >&*.*+-* 8&> 5&*. 200 /4005+. M&*+*+. +&+6. * 5&5>&>**+ 56 .> '58'6. E&-65>.*+ : 5, 55 .58, ,-6 >&>.-

3 B&*68'5'* : -&,'5>'- '8 &8 M&*+58 >&*7&>* -&58,.65 > 8+.* >'-6.5, 8,6 &*,.6 M6 -&*7 >**+6&.*++ ?-> .8&.-* 1 -,. 6&.

4 A'>'>'* : 5&5.,.-. &&- *. .*@56.


28/29

DAFTAR PUSTAKAF P,6&* #6?-& 2012 A,6 A*'5. M*6. S'8' E.6. 23 .,. 1 -: EG

G*=* SG et al 2012 ,armakologi dan %erapi edisi . -: B,. P&*&8. FKUI

K5 J A886 A F6' N * M.?&,, RN 200"# obbins Basi0 1athology 2thEditionP.,&,>.: E,6&C.&

L'*+' DL et al 2012 H.6'*Q6 P.*?.>,&6 O I*&*, M&.?.*& 1$ & N&= Y'-:M?G=H.,,

M7 R K & , 2012 B.'-.5. H>& E.6. 29 -: EG

P.?& S7,C. A*&6'* 200 1ato3siologi (onsep (linis 1roses-1roses 1enyakit# E.6. JI C', 1- : EG

S'7' A # et al 2014 Buku A4ar Ilmu 1enyakit !alam 5ilid III Edisi 6I -: I*&*P8,.6.*+

S756. HM 2014 (inesiologi -: FKUY

>:&5&.?.*&5&6?>&?'5.?,&3299%$/'C&C.&=(??&66& S&> 10 201% 0$1% >5)
http://emedicine.medscape.com/article/329958-overviewhttp://emedicine.medscape.com/article/329958-overview


29/29

sk 1 blok moskulo a14

Documents